Concepedia

Devikala Gurusamy

DG

22

Publications

1.8K

Citations

16

H-Index

2009

Active since

Affiliations

National Cancer Institute(Current)

National Institutes of Health

Center for Cancer Research

National Institute of Allergy and Infectious Diseases

University of Pennsylvania

Devikala Gurusamy is an author at National Cancer Institute specializing in medicine, cell biology, and immunology.

ORCID

Top concepts

Publications per year

2009–2022

22

Publications

22

Stem-like CD8 T cells mediate response of adoptive cell immunotherapy against human cancer

Sri Krishna, Frank J. Lowery, Amy R. Copeland et al. · Science · 2020 · 510 citations · Full text

Inhibition of AKT signaling uncouples T cell differentiation from expansion for receptor-engineered adoptive immunotherapy

Christopher A. Klebanoff, Joseph G. Crompton, Anthony Leonardi et al. · JCI Insight · 2017 · 211 citations · Full text

The transcription factor c-Myb regulates CD8+ T cell stemness and antitumor immunity

Sanjivan Gautam, Jessica Fioravanti, Wei Zhu et al. · Nature Immunology · 2019 · 173 citations

, , +8

T cells genetically engineered to overcome death signaling enhance adoptive cancer immunotherapy

Tori N. Yamamoto, Ping‐Hsien Lee, Suman K. Vodnala et al. · Journal of Clinical Investigation · 2019 · 153 citations · Full text

, , +15

Multi-phenotype CRISPR-Cas9 Screen Identifies p38 Kinase as a Target for Adoptive Immunotherapies

Devikala Gurusamy, Amanda N. Henning, Tori N. Yamamoto et al. · Cancer Cell · 2020 · 149 citations · Full text

, , +7

Rows per page

1–5 of 22